Hi Jase
Gene editing is certainly not my field.
I was wondering what the FDA's response would be to a 'crafted' trial that only accepted patients showing a higher level of T cell diversity.
The response rate could be phenomenal ... and lead to a very fast approval. Of course, I could be dreaming too.
Just my musings.
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-49
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
-0.001(1.56%) |
Mkt cap ! $468.4M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.5¢ | 6.3¢ | $502.0K | 7.929M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 257793 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.4¢ | 1089759 | 14 |
View Market Depth
| Last trade - 10.43am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
-0.001 ( 1.56 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.5¢ | 6.3¢ | 5839627 | ||
| Last updated 11.03am 04/06/2024 ? | |||||
| IMU (ASX) Chart |